MRI in Renal Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

39 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-10-31

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diagnostic imaging for renal masses of unknown nature using conventional imaging modalities such as 3 phase contrast-enhanced computed tomography (CT) is not always conclusive. After (partial) nephrectomy, 10-20 % of the resected tumors show benign histology which could not be identified on diagnostic imaging. With improved imaging techniques available, leading to improvements in characterisation of renal tumors, the number of unnecessary resections may be reduced. The objective of this study is to assess the ability to discriminate oncocytoma from RCC based on the ADC distribution parameters with addition of, tumor volume, and patient demographic characteristics.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Improvements in Dynamic Contrast-Enhanced MR Angiography and Perfusion and Non-Contrast MRI

NCT06315595

Prostate Neoplasm

RECRUITING

MRI Technical Development and Applications in Kidney Disease

NCT02421497

Chronic Kidney Diseases Kidney Transplantation Dialysis +1 more

NOT_YET_RECRUITING

Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)

NCT02417714

Healthy Subjects

RECRUITING

Magnetic Resonance Imaging for Evaluating Kidney Function

NCT00006173

Healthy Renovascular Hypertension

COMPLETED

High Image Matrix CT Reconstruction

NCT02610465

Healthy Subjects Pulmonary-Related Conditions Cardiac-Related Conditions

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Cell Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Renal tumor.

Patients \>18 years of age with histopathologically confirmed renal tumor diagnosis.

Magnetic Resonance Imaging

Intervention Type DEVICE

One MRI examination, diagnostic scanning protocol as used for renal tumours with additional diffusion weighted sequences, but without contrast enhancement.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic Resonance Imaging

One MRI examination, diagnostic scanning protocol as used for renal tumours with additional diffusion weighted sequences, but without contrast enhancement.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Radiologic diagnosis of renal tumor based on previous ultrasonography, CT or MRI examinations.
* Signed Institutional Review Board (IRB) approved informed consent form.
* Being at least 18 years of age.
* Histopathologically confirmed renal tumor diagnosis.

Exclusion Criteria

* Relative contra indications for MRI (metal device/foreign bodies, claustrophobia);
* Active renal or perirenal infection;
* Minor and/or incapacitated adult.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes